Benefits and Costs of Integrating Sexual-Reproductive Health and HIV Services in Kenya and Swaziland

There are many well-established reasons that support the rationale for integrating or linking sexual and reproductive health (SRH) and HIV services in developing countries with generalized HIV epidemics - primarily in sub-Saharan Africa. Yet the evidence base for the impact of integrated service delivery on health outcomes and costs remains weak. Partly this is a result of methodological difficulties.

There is an emerging body of literature addressing the challenges of using randomized controlled trials to assess the impact of public health interventions. Particularly in cases such as the Integra Initiative, where the causal chain (between intervention and outcome) is long, and where there are is a broad range of outcomes that need to be explored, and where there is already some a degree of integration occurring in some clinic settings, attempting to conduct a randomized controlled trial is not appropriate. Consistent with evaluation designs described by Habicht and colleagues, the Integra design includes evaluation of performance and impact to try to make two types of causal inference: adequacy and plausibility.

Evaluation of adequacy will assess whether the expected changes in provision, service utilisation and cost-effectiveness have occurred in intervention facilities. Evaluation of impact will assess the plausibility that changes in service, health and behavioral outcomes are due to the Integra Initiative. The case for such plausibility will be built from the following strands of evidence:

• Comparing findings in 'intervention' facilities with those in facilities chosen as 'comparison' sites prior to the evaluation
• Exploring a dose-response relationship between the measured extent of integration and the study outcomes
• Measuring changes in performance over time, to demonstrate a logical sequence between the intervention (integration) and outcomes.
• Measuring change in each step of the logic model - a prerequisite for any attribution to the intervention
• Triangulating findings from a mix of research methods to capture a range of perspectives and insights from different disciplines.

The study will employ a controlled pre- and post-test quasi-experimental, or non-randomised, design and utilises multiple research methods (cohort study, community survey, clinic assessments, costing tools and qualitative interviews). Since the research is being conducted in real-life health delivery settings where programmatic contamination is possible due to ongoing health programme interventions over the study period, the control group will be referred to as a 'comparison group', for which outcomes will be compared over time up to two years after implementation.

Inclusion criteria

for FP-HIV study:

• women aged 15 years and over,
• be revisit FP clients,
• be living in the catchment area of the health facility, and
• willing to give their informed consent to be interviewed.

Inclusion criteria

for PNC-HIV study:

• women aged 15 years and over,
• be postnatal clients attending a postnatal check for themselves and/or their infant (0-10 weeks),
• living in the catchment area of the health facility, and
• willing to give their informed consent to be interviewed.